Filter Results:
(299)
Show Results For
- All HBS Web
(620)
- People (1)
- News (203)
- Research (299)
- Events (3)
- Multimedia (10)
- Faculty Publications (172)
Show Results For
- All HBS Web
(620)
- People (1)
- News (203)
- Research (299)
- Events (3)
- Multimedia (10)
- Faculty Publications (172)
Page 1 of 299
Results →
Sort by
- April 2014 (Revised March 2018)
- Case
Texas Children's Hospital: Congenital Heart Disease Care
By: Michael E. Porter, Justin M. Bachmann and Zachary C. Landman
In 2014, Dr. Charles D. Fraser Jr., Surgeon-in-Chief of Texas Children's Hospital in Houston, was contemplating the future direction of the congenital heart disease program. The nation's largest pediatric hospital, Texas Children's was ranked by U.S. News & World... View Details
Keywords: Health Care; Congenital Heart Disease; Integrated Practice Units; Health Care and Treatment; Outcome or Result; Measurement and Metrics; Performance Improvement; Health Industry; United States; Texas
Porter, Michael E., Justin M. Bachmann, and Zachary C. Landman. "Texas Children's Hospital: Congenital Heart Disease Care." Harvard Business School Case 714-507, April 2014. (Revised March 2018.)
- February 2019
- Article
Who Benefits Most in Disease Management Programs: Improving Target Efficiency
By: Timothy Simcoe, Maryaline Catillon and Paul Gertler
Disease management programs aim to reduce cost by improving the quality of care for chronic diseases. Evidence of their effectiveness is mixed. Reducing health care spending sufficiently to cover program costs has proved particularly challenging. This study uses a... View Details
Keywords: Health Economics; Target Efficiency; Diabetes; Disease Management; Program Evaluation; Heterogeneity; Economics; Health; Quality; Health Care and Treatment; Cost Management; Health Industry
Simcoe, Timothy, Maryaline Catillon, and Paul Gertler. "Who Benefits Most in Disease Management Programs: Improving Target Efficiency." Health Economics 28, no. 2 (February 2019): 189–203.
- March 2021
- Article
Provider Teams Outperform Solo Providers in Managing Chronic Diseases and Could Improve the Value of Care
By: Maximilian J. Pany, Lucy Chen, Bethany Sheridan and Robert S. Huckman
Scope-of-practice regulations, including prescribing limits and supervision requirements, may influence the propensity of providers to form care teams. Therefore, policy makers need to understand the effect of both team-based care and provider type on clinical... View Details
Keywords: Disease Management; Team-based Care; Health Care and Treatment; Groups and Teams; Performance
Pany, Maximilian J., Lucy Chen, Bethany Sheridan, and Robert S. Huckman. "Provider Teams Outperform Solo Providers in Managing Chronic Diseases and Could Improve the Value of Care." Health Affairs 40, no. 3 (March 2021): 435–444.
- June 2020
- Article
Overcoming Barriers to Early Disease Intervention
By: H. Hugo Caicedo, Daniel A. Hashimoto, Julio C. Caicedo, Alex Pentland and Gary P. Pisano
It is widely acknowledged that earlier intervention in many disease processes leads to better patient outcomes and lower treatment costs. To date, most efforts at early disease intervention have focused on "primary prevention" which focuses on preventing diseases in... View Details
Caicedo, H. Hugo, Daniel A. Hashimoto, Julio C. Caicedo, Alex Pentland, and Gary P. Pisano. "Overcoming Barriers to Early Disease Intervention." Nature Biotechnology 38, no. 6 (June 2020).
- 1984
- Book
The American Disease
By: George C. Lodge
Keywords: United States
Lodge, George C. The American Disease. Alfred A. Knopf, 1984.
- 17 Nov 2003
- Research & Ideas
The Business Case for Diabetes Disease Management
analyze the complexities of disease management and check all avenues for potential business opportunities. The participants, almost all of them health professionals, sorted through the risks and benefits of View Details
- 2014
- Chapter
Disease Surveillance, Case Study
By: Skyler Speakman, Sriram Somanchi, Edward McFowland III and Daniel B. Neill
Speakman, Skyler, Sriram Somanchi, Edward McFowland III, and Daniel B. Neill. "Disease Surveillance, Case Study." In Encyclopedia of Social Network Analysis and Mining, edited by Reda Alhajj and Jon Rokne, 380–385. New York: Springer, 2014.
- April 1985
- Case
Netherlands and the Dutch Disease
Meerschwam, David M. "Netherlands and the Dutch Disease." Harvard Business School Case 385-317, April 1985.
- Article
Why Apps for Managing Chronic Disease Haven't Been Widely Used, and How to Fix It
By: Robert S. Huckman and Ariel Dora Stern
Keywords: Health Care; Digital Health; Chronic Disease; App; Health Information Technology; Information Technology; Health Industry; United States
Huckman, Robert S., and Ariel Dora Stern. "Why Apps for Managing Chronic Disease Haven't Been Widely Used, and How to Fix It." Harvard Business Review (website) (April 4, 2018).
- January 2023
- Case
The END Fund: To Eliminate Neglected Tropical Diseases
By: V. Kasturi Rangan and Courtney Han
Founded in 2012, the END fund focused on eliminating five Neglected Tropical Diseases that accounted for 80% of the tropical diseases affecting nearly 1.5 billion people worldwide. Its roughly $25 million/year annual budget was fully committed when it got news that the... View Details
Keywords: Nonprofit Organizations; Health Disorders; Health Care and Treatment; Resource Allocation; Global Range; Decisions; Investment Funds
Rangan, V. Kasturi, and Courtney Han. "The END Fund: To Eliminate Neglected Tropical Diseases." Harvard Business School Case 523-063, January 2023.
- Article
Race/Ethnicity and Patient Confidence to Self-manage Cardiovascular Disease
BACKGROUND: Minority populations bear a disproportionate burden of chronic disease, due to higher disease prevalence and greater morbidity and mortality. Recent research has shown that several factors, including confidence to self-manage care, are associated... View Details
Blustein, Jan, Melissa Valentine, Holly Mead, and Marsha Regenstein. "Race/Ethnicity and Patient Confidence to Self-manage Cardiovascular Disease." Medical Care 46, no. 9 (September 2008).
- October 2023
- Case
Vida Health: Transforming Chronic Disease Treatment
By: William Sahlman and Nicole Tempest Keller
San Francisco based Vida Health, founded by Stephanie Tilenius, former vice president of Commerce and Payments at Google, was a B2B digital health startup focused on the treatment of cardiometabolic conditions, such as diabetes and obesity. Its innovative digital... View Details
Keywords: Corporate Strategy; Growth and Development Strategy; Demand and Consumers; Health Care and Treatment; Product Marketing; Risk and Uncertainty; Technological Innovation; Health Industry; Technology Industry; United States; California; San Francisco
Sahlman, William, and Nicole Tempest Keller. "Vida Health: Transforming Chronic Disease Treatment." Harvard Business School Case 824-001, October 2023.
- March 2014
- Editorial
Limits on Use of Health Economic Assessments for Rare Diseases
By: Hanna I. Hyry, Ariel Dora Stern, Jonathan CP Roos and Timothy M. Cox
Funding of expensive treatments for rare ('orphan') diseases is contentious. These agents fare poorly on 'efficiency' or health economic measures, such as the QALY, because of high cost and frequently poor gains in quality of life and survival. We show that... View Details
Hyry, Hanna I., Ariel Dora Stern, Jonathan CP Roos, and Timothy M. Cox. "Limits on Use of Health Economic Assessments for Rare Diseases." hcu016. QJM: An International Journal of Medicine 107, no. 3 (March 2014): 241–245.
- September 30, 2020
- Article
How Nonprofit Foundations Can Sustainably Fund Disease Research
By: Richard G. Hamermesh and Kathy Giusti
Hamermesh, Richard G., and Kathy Giusti. "How Nonprofit Foundations Can Sustainably Fund Disease Research." Harvard Business Review Digital Articles (September 30, 2020).
- Editorial
Assessment of Economic Vulnerability to Infectious Disease Crises
By: Peter A Sands, Anas El Turabi, Philip Saynisch and Victor J Dzau
Sands, Peter A., Anas El Turabi, Philip Saynisch, and Victor J Dzau. "Assessment of Economic Vulnerability to Infectious Disease Crises." Lancet 388, no. 10058 (November 12, 2016): 2443–2448.
- May 2021
- Case
The SMA Foundation: Steering Therapeutic Research and Development in a Rare Disease
By: Amitabh Chandra, Spencer Lee-Rey and Caroline Marra
This case explores incentives for rare disease drug development by chronicling the role of the Spinal Muscular Atrophy (SMA) Foundation in forming strategic partnerships with the scientific research community and pharmaceutical developers to transform the trajectory... View Details
Keywords: Innovation and Invention; Strategy; Business or Company Management; Society; Health; Public Administration Industry; Health Industry; United States
Chandra, Amitabh, Spencer Lee-Rey, and Caroline Marra. "The SMA Foundation: Steering Therapeutic Research and Development in a Rare Disease." Harvard Business School Case 621-112, May 2021.
- 2013
- Case
Advanced Leadership Pathways: General Gale Pollock and Services for the Vision Impaired
By: Rosabeth M. Kanter, Juliane Calingo Schwetz and Patricia Bissett Higgins
In July 2012, retired United States Army Major General Gale Pollock created Elevivo, a venture that worked on developing a comprehensive disease management software system to support the growing number of visually impaired individuals by providing them with tailored... View Details
Keywords: Disease Management; Health; Health Care and Treatment; Education; Information Technology; Insurance; Entrepreneurship; Leadership; Information Technology Industry; Health Industry; United States
Kanter, Rosabeth M., Juliane Calingo Schwetz, and Patricia Bissett Higgins. "Advanced Leadership Pathways: General Gale Pollock and Services for the Vision Impaired." Harvard Business Publishing Case 314-029, 2013.
- July 2023
- Teaching Note
Hello Heart: The Next Generation of Chronic Disease Management Apps
By: Ariel Dora Stern and Kumba Sennaar
Teaching Note for HBS Case No. 622-061. View Details
- January 2022 (Revised August 2022)
- Case
Hello Heart: The Next Generation of Chronic Disease Management Apps
By: Ariel D. Stern and Danielle Golan
Hello Heart, a hypertension management app debated whether to go deep and cover other heart conditions, or to expand its solution to other chronic conditions. View Details
Keywords: Health; Health Care and Treatment; Information Technology; Mobile and Wireless Technology; Analysis; Business Startups; Transition; Customer Focus and Relationships; Customer Satisfaction; Decision Making; Demographics; Design; Entrepreneurship; Venture Capital; Technological Innovation; Growth and Development Strategy; Product Launch; Product Design; Product Development; Business Strategy; Competitive Strategy; Competitive Advantage; Customization and Personalization; Business Growth and Maturation; Business Model; Strategy; Applications and Software; Health Industry; Technology Industry; Israel; United States
Stern, Ariel D., and Danielle Golan. "Hello Heart: The Next Generation of Chronic Disease Management Apps." Harvard Business School Case 622-061, January 2022. (Revised August 2022.)
- August 18, 2020
- Article
What It Takes to Lead a Disease Research Foundation
By: Richard G. Hamermesh and Kathy Giusti
Hamermesh, Richard G., and Kathy Giusti. "What It Takes to Lead a Disease Research Foundation." Harvard Business Review Digital Articles (August 18, 2020).